A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts

A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts, special issue of American Journal of Preventive Medicine

key takeaway, from the conclusion article, "'The Real Cost' Campaign: Efficacy by Design": "An evaluation from 2014 to 2016 found that “The Real Cost” cigarette prevention campaign prevented up to 587,000 youth from starting to smoke, and more recently, an evaluation found that the e-cigarette prevention campaign prevented nearly 450,000 youth aged 11–18 from starting e-cigarette use between 2023 and 2024."